Euglena Co., Ltd.

Tokyo Stock Exchange 2931.T

Euglena Co., Ltd. Capital Expenditure for the year ending December 31, 2022: USD -3.78 M

Euglena Co., Ltd. Capital Expenditure is USD -3.78 M for the year ending December 31, 2022, a -25.20% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Euglena Co., Ltd. Capital Expenditure for the year ending September 30, 2021 was USD -3.02 M, a 19.03% change year over year.
Euglena Co., Ltd. Capital Expenditure for the year ending September 30, 2020 was USD -3.73 M, a 70.75% change year over year.
Euglena Co., Ltd. Capital Expenditure for the year ending September 30, 2019 was USD -12.75 M, a 55.49% change year over year.
Euglena Co., Ltd. Capital Expenditure for the year ending September 30, 2018 was USD -28.65 M, a 16.37% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

Tokyo Stock Exchange: 2931.T

Euglena Co., Ltd.

CEO	Mr. Tomohiro Wakahara
IPO Date	Dec. 21, 2012
Location	Japan
Headquarters	G-BASE Tamachi
Employees	846
Sector	Energy
Industries Biofuel Biotechnology Cosmetics Dairy & Milk Frozen Foods Non-Alcoholic Beverages Personal Care Plastics

Description

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae. It operates through Healthcare Business and Energy/Environment Business segments. The company also manufactures and sells foods and cosmetics using euglena. In addition, it offers health foods, beverages, confectionery, and sports food products. Further, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business. It distributes its products at convenience stores, drugstores, supermarkets, beauty salons, and variety shops. The company was incorporated in 2005 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years